基于慢性病继发骨质疏松的代谢机制及中医药治疗  

Metabolic Mechanism and Traditional Chinese Medicine Treatment of Osteoporosis Secondary to Chronic Diseases

作　　者：蔡维嘉 王建伟[2] CAI Wei-jia;WANG Jian-wei(Graduate school of Nanjing University of Chinese Medicine,Nanjing 213002,China;Department of Orthorpedics&Traumatology,Wuxi Traditional Chinese Medicine Hospital,Wuxi 214071,China)

机构地区：[1]南京中医药大学,江苏南京210023 [2]南京中医药大学无锡附院骨伤科,江苏无锡214071

出　　处：《药物生物技术》2022年第4期414-418,共5页Pharmaceutical Biotechnology

摘　　要：研究发现慢性病患者因疾病本身及长期服用药物导致继发性骨质疏松的发病率逐年增长,中医药在治疗继发性骨质疏松具有不良反应小、患者依从性高、药物代谢影响小等优势。文章从中西医两方面对继发性骨质疏松发病机制进行概括,为继发性骨质疏松的防治提供新的治疗理念。Studies have found that the incidence of secondary osteoporosis in patients with chronic diseases due to the disease itself and long-term use of drugs has increased year by year.Traditional Chinese medicine in the treatment of secondary osteoporosis has the advantages of less adverse reactions,high patient compliance,and less impact on drug metabolism.This paper summarized the pathogenesis of secondary osteoporosis from both traditional Chinese and western medicine,and provided a new treatment concept for the prevention and treatment of secondary osteoporosis.

关 键 词：中医中药 慢性病 继发性骨质疏松 代谢机制 发病机制 NEI网络 

分 类 号：R683[医药卫生—骨科学]